Assessing the Impact of the NeuroCatch Platform 2 Stimulus Tone Volume

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 12, 2021

Primary Completion Date

August 31, 2021

Study Completion Date

December 31, 2021

Conditions
Brain Health
Interventions
DEVICE

NeuroCatch Platform 2

To elicit the ERP components of interest in this study (N100, P300, N400), proprietary auditory stimulus sequences will be administered using the NeuroCatch Platform 2, an investigational medical device. Each sequence consists of tones and word pairs to elicit the various components of interest. The NeuroCatch Platform 2 consists of a computerized acquisition software which presents the stimulus, acquires the data and presents the amplitude and latency values of the ERP components (N100, N400, P300)

Trial Locations (1)

V3V 0C6

HealthTech Connex Centre for Neurology Studies, Surrey

All Listed Sponsors
lead

NeuroCatch Inc.

INDUSTRY